-- 根據多家媒體報道,印度已允許四艘伊朗油輪停靠,這標誌著印度罕見地放寬了對伊朗原油的限制。 報道稱,應信實工業(Reliance Industries)的請求,印度航運部批准了載有伊朗原油的船舶停靠錫卡港。 印度是世界第三大石油進口國,在2019年迫於美國壓力停止購買伊朗原油。 此前,美國上月發布了一項臨時豁免,允許在海上進行有限的伊朗石油交易,以幫助穩定全球油價。 該豁免將於4月19日到期,在當前地緣政治緊張局勢加劇的情況下,進口商迫切需要尋找替代供應來源。 伊朗原油通常由缺乏標準保險和認證的船舶運輸,因此需要根據印度海事法規獲得政府的特別批准。 獲準停靠的船舶包括阿芙拉型油輪「卡維茲號」(Kaviz)以及超大型原油運輸船「萊諾爾號」(Lenore)、「費利西蒂號」(Felicity)和「赫迪號」(Hedy),這些船舶均受到美國制裁。 每艘超級油輪最多可裝載200萬桶原油,如果這些貨物已加工,則潛在產量龐大。 報告稱,追蹤數據顯示,4月初一些油輪停泊在伊朗恰巴哈爾港附近,而其他油輪最近裝載了貨物或離開了波斯灣。 儘管已獲得批准,但由於信實產業正在評估是否符合製裁和國內法規,因此該公司是否會提煉這些原油仍存在不確定性。 此外,印度石油公司已透過一艘受制裁的油輪接收了伊朗原油,這表明在特殊情況下,原油運輸已有限度地恢復。 印度港口、航運和水路部以及信實工業尚未回覆的置評請求。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.